Hims & Hers Health (HIMS) said Thursday it launched "Labs" to offer an affordable and data-driven testing experience for customers.
Customers will receive detailed insights into health, with reports paired with doctor-developed action plans as well as lifestyle recommendations and access to customized treatment plans if necessary, the company said.
The company plans to expand Labs over time with at-home testing devices, extra biomarker tests in domains such as bone and brain health, and diagnostics to detect life-threatening conditions, according to a statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.